Progress toward elimination mother-to-child transmission of HBV in Shandong Province, China: Coverage trend in hepatitis B vaccination and HBIG administration, 2017-2024. [PDF]
Meng X+5 more
europepmc +1 more source
State‐of‐the‐Art Fabrication of Microneedle Patches: A Mini‐Review on Emerging Techniques
This mini‐review explores state‐of‐the‐art microneedle (MN) fabrication techniques, comparing conventional and emerging methods such as electrospinning and bioprinting. The analysis highlights advancements in precision, scalability, and material compatibility, offering insights into optimizing MN design for transdermal drug delivery, diagnostics, and ...
Syed Waqas Ali Shah+6 more
wiley +1 more source
Healthcare personnel on the frontline of immunization: Barriers to vaccination and the path to full coverage. [PDF]
Aksu SB+4 more
europepmc +1 more source
RNA Modifications in Health and Disease
Changes in these components profoundly affect the m6A methylation process, leading to a range of physiological and pathological alterations. In recent years, research on the post‐translational modifications of these components has advanced, encompassing ubiquitination, phosphorylation, SUMOylation, O‐GlcNAcylation, and lactylation.
Shiqi Li+5 more
wiley +1 more source
High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease. [PDF]
Hegde Y+5 more
europepmc +1 more source
Recent Progress in Gene Delivery Systems Based on Gemini‐Surfactant
Gene delivery is a key area in biomedicine, where nucleic acids are delivered into cells to treat diseases by modulating genes. The low micelle concentration, effective nucleic acid complexation, and low immunogenicity make Gemini surfactants promising gene delivery vectors.
Peng Qian+5 more
wiley +1 more source
Association between hepatitis A B vaccination and hearing loss across frequencies based on NHANES. [PDF]
Qie RJ, Qin JB, Ji ZH.
europepmc +1 more source
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun+10 more
wiley +1 more source
The emerging role of the gut microbiota in vaccination responses. [PDF]
Decker V+6 more
europepmc +1 more source